东长春药膏治疗中度至重度慢性阻塞性肺病:一个多中心,前性,开放标签,随机对照试验
Zhang Yibao1, Chen Feng1, Sun Meng1
1Department of Pulmonary Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200021, China.
东长春膏 (DTCO) 在中度至重度疾病患者中显著降低了COPD (AECOPD) 的急性恶化. 这项研究发现DTCO是COPD管理的安全有效的治疗选择.
科学领域:
- 肺部医学 肺部医学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 慢性阻塞性肺病 (COPD) 是一个主要的全球健康问题.
- 管理稳定的中度至重度COPD需要有效和安全的治疗干预措施.
- 慢性肺炎的急性恶化 (AECOPD) 显著影响患者的治疗结果和医疗费用.
研究的目的:
- 评估Dongtian Changchun膏 (DTCO) 的临床疗效和安全性,用于治疗稳定的中度至重度COPD.
- 评估DTCO对AECOPD频率和持续时间的影响.
- 确定DTCO对COPD患者肺功能和生活质量的影响.
主要方法:
- 进行了一项多中心,前性,开放标签,随机对照试验.
- 84名中度至重度COPD患者被随机分配到DTCO和对照组.
- 两组都接受了标准治疗;DTCO组接受了12周的额外DTCO,在48周的多个时间点进行评估.
主要成果:
- 与对照组相比,DTCO组的AECOPD频率和持续时间显著减少 (P <0.05).
- 在DTCO组中,AECOPD的发病率明显较低 (P = 0.006).
- 在DTCO组中观察到强迫生命能力和修改的医学研究委员会 (mMRC) 评分的改善,但不良事件没有显著差异.
结论:
- 东长春膏 (DTCO) 有效地减少了中度至重度COPD患者的AECOPD的频率和持续时间.
- DTCO在COPD管理方面表现出令人满意的安全性.
- DTCO为改善COPD患者的治疗结果提供了一个有前途的治疗选择.
更多相关视频
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
04:53Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
